Waleed Sabry

655 total citations
23 papers, 266 citations indexed

About

Waleed Sabry is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Waleed Sabry has authored 23 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Oncology and 6 papers in Genetics. Recurrent topics in Waleed Sabry's work include Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Waleed Sabry is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Waleed Sabry collaborates with scholars based in Canada, Taiwan and United States. Waleed Sabry's co-authors include Hadi Goubran, Jerard Seghatchian, Thierry Burnouf, Rami Kotb, Mohamed Elemary, Thomas Kiss, Jean Roy, Julie Stakiw, Silvy Lachance and Hillard M. Lazarus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Waleed Sabry

21 papers receiving 259 citations

Peers

Waleed Sabry

HEMAT

ONCOL

IMMUN

PFM

Elizabeth H. Cull United States

Anup J. Devasia India

Masato Moriyama Japan

Radha Raghupathy Hong Kong

Minodora Onisâi Romania

Yasufumi Matsuda Japan

Mauro Turrini Italy

Amr Hanbali United States

Dawn Swan Ireland

Manuela Rizzo Italy

Elizabeth H. Cull United States

Waleed Sabry

117 ×0.8

HEMAT

100 ×1.0

ONCOL

101 ×1.1

48 ×1.5

IMMUN

19 ×0.6

PFM

Citations per year, relative to Waleed Sabry Waleed Sabry (= 1×) peers Elizabeth H. Cull

Countries citing papers authored by Waleed Sabry

Since Specialization

Citations

This map shows the geographic impact of Waleed Sabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waleed Sabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waleed Sabry more than expected).

Fields of papers citing papers by Waleed Sabry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waleed Sabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waleed Sabry. The network helps show where Waleed Sabry may publish in the future.

Co-authorship network of co-authors of Waleed Sabry

This figure shows the co-authorship network connecting the top 25 collaborators of Waleed Sabry. A scholar is included among the top collaborators of Waleed Sabry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waleed Sabry. Waleed Sabry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sy, Eric, et al.. (2025). Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. Current Oncology. 32(6). 296–296.

Chang, Yoon Hwan, et al.. (2024). Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcome in a Canadian Real-World Setting. Blood. 144(Supplement 1). 6796–6796.

Sabry, Waleed, et al.. (2024). Polymorphism in Pseudo‐Exon 5 Defines the Novel HLA‐DQB1*02:02:01:14 Allele. HLA. 104(6). e15788–e15788. 1 indexed citations

Kakodkar, Pramath, Fang‐Xiang Wu, Mohamed Elemary, et al.. (2023). Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation. Frontiers in Genetics. 14. 1282947–1282947. 3 indexed citations

Goubran, Hadi, Gaafar Ragab, & Waleed Sabry. (2022). Metabolism-mediated thrombotic microangiopathy and B12. Vitamins and hormones. 119. 441–455. 1 indexed citations

Goubran, Hadi, Jerard Seghatchian, Waleed Sabry, Gaafar Ragab, & Thierry Burnouf. (2022). Platelet and extracellular vesicles in COVID-19 infection and its vaccines. Transfusion and Apheresis Science. 61(3). 103459–103459. 12 indexed citations

Olszewski, Adam J., Lihua E. Budde, Nilanjan Ghosh, et al.. (2022). Mosunetuzumab with Polatuzumab Vedotin Is Effective and Has a Manageable Safety Profile in Patients Aged <65 and ≥65 Years with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) and ≥1 Prior Therapy: Subgroup Analysis of a Phase Ib/II Study. Blood. 140(Supplement 1). 3757–3759. 12 indexed citations

Lim, Hyun Ju, et al.. (2021). BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy. Scientific Reports. 11(1). 14071–14071. 15 indexed citations

Sabry, Waleed, et al.. (2021). Real World Clinical Experience of Biosimilar G-CSF (Grastofil) for Autologous Peripheral Blood Stem Cell Mobilization: Single Center Experience in Canada Following Early Adoption. Current Oncology. 28(3). 1571–1580. 1 indexed citations

10.

Sabry, Waleed, Mohamed Elemary, Thierry Burnouf, Jerard Seghatchian, & Hadi Goubran. (2019). Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA). Transfusion and Apheresis Science. 59(1). 102717–102717. 25 indexed citations

11.

Elemary, Mohamed, Waleed Sabry, Jerard Seghatchian, & Hadi Goubran. (2019). Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies. Transfusion and Apheresis Science. 58(3). 347–350. 4 indexed citations

12.

Goubran, Hadi, Jerard Seghatchian, Oksana Prokopchuk‐Gauk, et al.. (2017). Reflections on multiple strategies to reduce transfusion in cancer patients: A joint narrative. Transfusion and Apheresis Science. 56(3). 322–329. 5 indexed citations

13.

Elemary, Mohamed, et al.. (2017). Transfusion challenges in hematology oncology and hematopoietic stem cell transplant – Literature review and local experience. Transfusion and Apheresis Science. 56(3). 317–321. 10 indexed citations

14.

Goubran, Hadi, Waleed Sabry, Rami Kotb, Jerard Seghatchian, & Thierry Burnouf. (2015). Platelet microparticles and cancer: An intimate cross-talk. Transfusion and Apheresis Science. 53(2). 168–172. 64 indexed citations

15.

Ahmad, Imran, Richard LeBlanc, Sandra Cohen, et al.. (2015). Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Bone Marrow Transplantation. 51(4). 529–535. 13 indexed citations

16.

Hay, Annette E., Suzanne Trudel, Nizar J. Bahlis, et al.. (2014). A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial.. Journal of Clinical Oncology. 32(15_suppl). 8591–8591. 1 indexed citations

17.

Stewart, A. Keith, Suzanne Trudel, Nizar J. Bahlis, et al.. (2010). A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial. Blood. 116(21). 39–39. 36 indexed citations

18.

Sabry, Waleed, Richard Le Blanc, Annie‐Claude Labbé, et al.. (2009). Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality. Biology of Blood and Marrow Transplantation. 15(8). 919–929. 30 indexed citations

19.

Sabry, Waleed, Annie‐Claude Labbé, Richard Le Blanc, et al.. (2008). Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome.. Blood. 112(11). 1176–1176. 6 indexed citations

20.

Kiss, Thomas, Waleed Sabry, Hillard M. Lazarus, & Jeffrey H. Lipton. (2007). Blood and marrow transplantation in elderly acute myeloid leukaemia patients – older certainly is not better. Bone Marrow Transplantation. 40(5). 405–416. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact